Inventor · disambiguated record
Jonathan Cebon
Also filed as: CEBON JONATHAN · CEBON JONATHAN S
5 granted patents·12 pending applications·10 citations·filing 2004–2020
71Inventor score
Files withCSL LTD4BLACK MICHAEL ALAN2CEBON JONATHAN1CSL LTD LUDWIG INST FOR CANCER1EBERT LISA MICHELLE1
Top patents by PatentIndex Score
17 records- 0181US8822149B2Prognosis prediction for melanoma cancerBLACK MICHAEL ALAN·Filed 2009·Granted Sep 2, 2014·7 cites·1 claims
- 0273US9534258B2Devices and methods for prognosis prediction for melanoma cancerPACIFIC EDGE LTD·Filed 2014·Granted Jan 3, 2017·2 cites·6 claims
- 0362US8420791B2Expression of FoxP3 by cancer cellsEBERT LISA MICHELLE·Filed 2007·Granted Apr 16, 2013·1 cites·5 claims
- 0459US2021292411A1Method of treating cancerCSL LTD·Filed 2020·Application pending·0 cites
- 0554US2016376364A1Method of treating cancerCSL LTD·Filed 2014·Application pending·0 cites
- 0653US8354243B2Method for determining presence of cancer in a sample by assaying for expression of ECSA/DPPA-2 nucleotide sequencesUCL BUSINESS PLC·Filed 2007·Granted Jan 15, 2013·0 cites·5 claims
- 0749US10266902B2Methods for prognosis prediction for melanoma cancerBLACK MICHAEL ALAN·Filed 2016·Granted Apr 23, 2019·0 cites·18 claims
- 0849US2021324035A1Composition of ny-eso-1-specific t cell receptors restricted on multiple major histocompatibility complex moleculesUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 0947US2007190072A1In vivo efficacy of ny-eso-1 plus adjuvantCSL LTD LUDWIG INST FOR CANCER·Filed 2004·Application pending·0 cites
- 1047US2019023783A1Method of treating cancerCSL LTD·Filed 2018·Application pending·0 cites
- 1145US2010279409A1Method for modifying celluar immune resonse by modulating activin activityROBSON NEIL·Filed 2008·Application pending·0 cites
- 1245US2022228222A1Cancer stratification and treatment based on Inhibition of NOD-2GOODNOW CHRISTOPHER·Filed 2020·Application pending·0 cites
- 1343US2022273713A1Method of inhibiting or activating gamma delta t cellsUNIV MELBOURNE·Filed 2020·Application pending·0 cites
- 1442US2010068142A1Melanoma repopulating cellsGEDYE CRAIG·Filed 2007·Application pending·0 cites
- 1537US2012171232A1In vivo efficacy of ny-eso-1 plus adjuvantCEBON JONATHAN·Filed 2011·Application pending·0 cites
- 1635US2016000894A1In vivo efficacy of ny-eso-1 plus adjuvantCSL LTD·Filed 2015·Application pending·0 cites
- 1732US2013011496A1Cancer testis antigens as biomarkers in non-small cell lung cancerLUDWIG INST FOR CANCER RES LTD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Cebon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →